Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York — 317 East 17th Street Room 7F05 8th Floor, New York

Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York is a clinical research site located in 317 East 17th Street Room 7F05 8th Floor, New York, United States 10003.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus.

Sponsors: Generex Biotechnology Corp..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York?

Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York conducted?

Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York has 1 clinical trials on record. Their work covers Diabetes Mellitus.

Is Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York accredited by Crixeo Health?

Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Medical Center, Geral J. Friedman Diabetes Institute at New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.